Economic stimulus for health care reform: signs of the times. - Examiner.com

Economic stimulus for health care reform: signs of the times. Examiner.com We are knee deep in health care reform bravado, banter, and bickering and I must ask, where did all the stimulus money go? Where did it go? ...

Cliffhanger health care vote expected to run late - San Francisco Chronicle

Boston Globe

Cliffhanger health care vote expected to run late San Francisco Chronicle Republicans are reprising their unified boycott of the stimulus, betting that independent voters are turning against Obama. That means House Speaker Nancy ... The House health care debate: What to watch for 2010 elections: Democratic fears, Republican hopes More spending, more debt, and fewer jobs under Speaker Pelosi's 2000-page ...  - -

Is the current health care reform bill practical? - Examiner.com

The Star-Ledger - NJ.com

Is the current health care reform bill practical? Examiner.com Earlier this year, President Obama said that if the stimulus bill was passed, the rate of unemployment would not exceed 8%. ... Heal the Economy, Start Over on Health Care Reform Health care bill is not the change Americans need Health bill needs a good hard edit  -

September 2009 OnBioVC | Trend Analysis Now Available

Hot off the press! The September 2009 OnBioVC | Trend Analysis study is now available for download [HERE]. Over $465M flowed into early-stage biopharma, diagnostic and device companies in the ninth month of 2009 and over $4,806M year-to-date! If you find the information in OnBioVC to be of value kindly forward on to colleagues who [...]

Celladon, Inc.: Series C $21.8M

Celladon (La Jolla, CA) a clinical-stage company focused on gene therapy for congestive heart failure, closed a $21.8M Series C financing. Participants include Enterprise Partners Venture Capital, Venrock and Johnson & Johnson Dev Corp.

Quanta Fluid Solutions, Ltd.: Series A $14.3M

Quanta Fluid Solutions (United Kingdom) a development-stage medical device company focused on haemodialysis systems for acute renal failure, has closed a $14.3M Series A financing. Participants include NBGI Ventures, Seroba Kernel Life Sciences, Wellington Partners Venture Capital and Brains-To-Ventures.

Calypso Medical Technologies, Inc.: Series E $50M

Calypso Medical Technologies (Seattle, WA) a commercial-stage medical device company focused on implantable sensor electromagnetic transponders, to accurately and continuously pinpoint the location of tumors in real-time during radiation therapy delivery, closed a $50M Series E financing. Participants include Skyline Ventures, Frazier Healthcare Ventures, Bay City Capital and InterWest Partners.

NextBio, Inc.: Series C $8M

NextBio (Cupertino, CA) a commercial-stage bioinformatics and competitive intelligence bioscience search engine, closed a $8M Series C financing. Participants include Newbury Ventures.